Stockreport

Genetic Modification Therapies Set to Surge, Market Valued at $32.1 Billion by 2030 [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Emerging applications extend to oncology, cardiovascular, and neurological diseases, supported by a robust clinical pipeline and growing biopharmaceutical industry inter [Read more]